This slide collection supports review of neoplastic hematopathology through the 2025 tutorial’s focus on evolving classifications. The curriculum connects morphology, immunophenotyping, and molecular genetics with the diagnosis of lymphoid and myeloid neoplasms. Sessions cover common and challenging lymphoma categories, acute and chronic leukemias, plasma cell disorders, histiocytic disease, and mastocytosis, alongside case presentations. For pathologists and trainees, the material offers a structured way to revisit classification criteria and the clinical significance of diagnostic findings. The complete original program below retains session order, faculty names, and timings, while the learning objectives outline the tutorial’s intended scope.
Format: Slides only, in English. No lecture videos are included. The course was held January 20–24, 2025, at the Renaissance Phoenix Downtown Hotel in Phoenix, Arizona, through the University of Chicago Department of Pathology. Daniel A. Arber, MD, served as course director, with Attilio Orazi, MD, as associate course director.
Scope: The program below preserves the original agenda, including case discussions, questions, and breaks; it is not a file-by-file inventory of the slides. University of Chicago registration, platform access, and ABPath credit are not included with these files.
Learning Objectives
- Identify how to evaluate and respond to diagnostic problems that arise in neoplastic hematopathology;
- State how to utilize recent advances in the classification of hematopoietic tumors;
- Discuss how to interpret and apply immunologic and molecular genetic findings in the diagnosis of neoplastic hematologic disease;
- Describe how to implement the most recent classification of hematologic neoplasms;
- Recall new discoveries that might impact future classifications of hematologic neoplasms;
- Understand the prognostic and therapeutic significance of new molecular genetic markers of these tumors.
ACGME / ABMS Core Competencies
- Medical Knowledge
- Practice-based Learning and Improvement
Program
Monday, January 20
| 8:00 AM | Introductory Remarks | Daniel Arber, MD |
| Morning Session
Chairperson: Daniel Arber, MD |
||
| 8:15 AM | Normal Lymph Nodes and Reactive Hyperplasias | Rebecca King, MD |
| 9:30 AM | Introduction to the Classification of Lymphoma | James Cook, MD |
| 10:15 AM | BREAK | |
| 10:30 AM | Monoclonal B Lymphocytosis, Chronic Lymphocytic Leukemia and Related B-Cell Leukemias | Kathy Foucar, MD |
| 11:45 AM | Questions | |
| 12:00 PM | LUNCH | |
| Afternoon Session
Chairperson: Kathy Foucar, MD |
||
| 1:30 PM | Chronic T/NK Cell Leukemias | Kathy Foucar, MD |
| 2:00 PM | Lymphoplasmacytic Lymphoma and Nodal and Extranodal Marginal Zone Lymphoma | James Cook, MD, PhD |
| 3:00 PM | Questions | |
| 3:15 PM | BREAK | |
| 3:30 PM | Mantle Cell Lymphoma, Follicular Lymphoma and Variants | Rebecca King, MD |
| 4:30 PM | Questions | |
| 4:45 PM-
5:30 PM |
Case Presentations | Rebecca King, MD, James Cook, MD, PhD &
Kathy Foucar, MD |
Tuesday, January 21
| Morning Session
Chairperson: Michael Borowitz, MD |
||
| 8:00 AM | Peripheral T Cell Lymphoma and Anaplastic Large Cell Lymphoma | Elaine Jaffe, MD |
| 9:30 AM | Questions | |
| 9:45 AM | BREAK | |
| 10:00 AM | Acute Lymphoblastic Leukemia/Lymphoma and Acute Leukemias of Ambiguous Lineage | Michael Borowitz, MD |
| 11:30 AM | Questions | |
| 11:45 AM | Case Presentations | Michael Borowitz, MD &
Elaine Jaffe, MD |
| 12:15 PM | LUNCH | |
| Afternoon Session
Chairperson: Rebecca King, MD |
||
| 1:45 PM | Diffuse, Aggressive B Cell Lymphomas | Rebecca King, MD |
| 2:45 PM | Questions | |
| 3:00 PM | BREAK | |
| 3:15 PM | Lymphoma Diagnosis: A Clinician’s Perspective | Javier Munoz, MD, MBA |
| 4:15 PM | Questions | |
| 4:30 PM-
5:00 PM |
Case Presentations | Rebecca King, MD |
Wednesday, January 22
| Morning Session
Chairperson: Jonathan Said, MD |
||
| 8:00 AM | Splenic Tumors | Daniel Arber, MD |
| 9:00 AM | Hodgkin Lymphoma | Amy Chadburn, MD |
| 10:00 AM | Questions | |
| 10:15 AM | BREAK | |
| 10:30 AM | Immunodeficiency-and Viral-Associated Lymphoproliferations | Jonathan Said, MD |
| 11:45 AM | Questions | |
| 12:00 PM | LUNCH | |
| Afternoon Session
Chairperson: Amy Chadburn, MD |
||
| 1:30 PM | Histiocytic Disorders | Amy Chadburn, MD |
| 2:45 PM | Questions | |
| 3:00 PM | BREAK | |
| 3:15 PM | Cutaneous Lymphomas | Jonathan Said, MD |
| 4:15 PM | Questions | |
| 4:30 PM-
5:00 PM |
Case Presentations | Daniel Arber, MD
Jonathan Said, MD & Amy Chadburn, MD |
Thursday, January 23
| Morning Session
Chairperson: Adam Bagg, MD |
||
| 8:00 AM | Introduction to the Classification of Myeloid Neoplasms and Acute Leukemia | Daniel Arber, MD |
| 8:45 AM | Chronic Myeloid Leukemia | Adam Bagg, MD |
| 9:30 AM | Questions | |
| 9:45 AM | BREAK | |
| 10:00 AM | BCR: ABL1–negative Myeloproliferative Neoplasms | Attilio Orazi, MD |
| 11:00 AM | Eosinophilic Disorders | Adam Bagg, MD |
| 11:45 AM | Questions | |
| 12:00 PM | LUNCH | |
| Afternoon Session
Chairperson: Robert Lorsbach, MD |
||
| 1:30 PM | Clonal Cytopenias and Myelodysplastic Syndrome | Robert Hasserjian, MD |
| 2:45 PM | Pediatric and Germline Predisposition Syndromes | Robert Lorsbach, MD |
| 3:30 PM | Questions | |
| 3:45 PM | BREAK | |
| 4:00 PM | Plasma Cell Neoplasms | Robert Lorsbach, MD, PhD |
| 4:45 PM | Questions | |
| 5:00 PM-
5:45 PM |
Case Presentations | Robert Hasserjian, MD & Robert Lorsbach, MD, PhD |
Friday, January 24
| Morning Session
Chairperson: Daniel Arber, MD |
||
| 8:00 AM | Myelodysplastic/Myeloproliferative Neoplasms | Attilio Orazi, MD |
| 9:00 AM | Acute Myeloid Leukemias | Daniel Arber, MD |
| 10:00 AM | Questions | |
| 10:15 AM | BREAK | |
| 10:30 AM | Mastocytosis | Attilio Orazi, MD |
| 11:15 AM | Case Presentations | Daniel Arber, MD & Attilio Orazi, MD |
| 11:45 AM | Questions | |
| 12:00 PM-
12:30 PM |
Concluding Remarks | |



